blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0829260

EP0829260 - Use of at least one pyrimidine derivative substituted in position 6 as stimulant of tyrosinase [Right-click to bookmark this link]
Former [1998/12]Use of at least one pyrimidine derivative substituted in position G as stimulant of tyrosinase
[2002/01]
StatusNo opposition filed within time limit
Status updated on  21.03.2003
Database last updated on 19.10.2024
Most recent event   Tooltip19.11.2004Lapse of the patent in a contracting state
New state(s): GR
published on 05.01.2005  [2005/01]
Applicant(s)For all designated states
L'Oréal
14, rue Royale
75008 Paris / FR
[N/P]
Former [1998/12]For all designated states
L'OREAL
14, rue Royale
75008 Paris / FR
Inventor(s)01 / Pruche, Francis
5, Villa Montcalm
75018 Paris / FR
02 / Gerst, Catherine
48, rue B. Jugault
92600 Asnieres / FR
[1998/12]
Representative(s)Tezier Herman, Béatrice
L'Oréal D.I.P.I. 6 rue Bertrand Sincholle
92585 Clichy Cédex / FR
[N/P]
Former [1998/12]Tezier Herman, Béatrice
L'OREAL, Département Propriété Industrielle, 90, rue du Gal Roguet
92583 Clichy Cédex / FR
Application number, filing date97401967.121.08.1997
[1998/12]
Priority number, dateFR1996001131617.09.1996         Original published format: FR 9611316
[1998/12]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0829260
Date:18.03.1998
Language:FR
[1998/12]
Type: B1 Patent specification 
No.:EP0829260
Date:15.05.2002
Language:FR
[2002/20]
Search report(s)(Supplementary) European search report - dispatched on:EP14.01.1998
ClassificationIPC:A61K7/48, A61K7/06, A61K7/42
[1998/12]
CPC:
A61Q19/04 (EP,US); A61K31/506 (EP,US); A61K31/513 (EP,US);
A61K8/4953 (EP,US); A61Q5/065 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/12]
TitleGerman:Verwendung mindestens eines in 6-Stellung substituierten Pyrimidin-3-oxids zur Stimulierung von Tyrosinase[2002/09]
English:Use of at least one pyrimidine derivative substituted in position 6 as stimulant of tyrosinase[2002/01]
French:Utilisation d'au moins un dérivé de pyrimidine 3-oxyde, substitué en 6 en tant que stimulateur de tyrosinase[1998/12]
Former [1998/12]Verwendung von mindestens einen G-substituierte Pyrimidinderivaten zur Stimulierung von Tyrosinase
Former [1998/12]Use of at least one pyrimidine derivative substituted in position G as stimulant of tyrosinase
Examination procedure18.09.1998Examination requested  [1998/47]
26.06.2001Despatch of communication of intention to grant (Approval: No)
17.10.2001Fee for grant paid
17.10.2001Fee for publishing/printing paid
05.11.2001Despatch of communication of intention to grant (Approval: later approval)
16.11.2001Communication of intention to grant the patent
Opposition(s)18.02.2003No opposition filed within time limit [2003/19]
Fees paidRenewal fee
11.08.1999Renewal fee patent year 03
16.08.2000Renewal fee patent year 04
14.08.2001Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.05.2002
FI15.05.2002
IE15.05.2002
NL15.05.2002
DK15.08.2002
SE15.08.2002
GR16.08.2002
PT16.08.2002
LU21.08.2002
BE31.08.2002
CH31.08.2002
LI31.08.2002
[2005/01]
Former [2004/40]AT15.05.2002
FI15.05.2002
IE15.05.2002
NL15.05.2002
DK15.08.2002
SE15.08.2002
PT16.08.2002
LU21.08.2002
BE31.08.2002
CH31.08.2002
LI31.08.2002
Former [2004/39]AT15.05.2002
IE15.05.2002
NL15.05.2002
DK15.08.2002
SE15.08.2002
PT16.08.2002
LU21.08.2002
BE31.08.2002
CH31.08.2002
LI31.08.2002
Former [2003/51]AT15.05.2002
IE15.05.2002
NL15.05.2002
DK15.08.2002
SE15.08.2002
PT16.08.2002
BE31.08.2002
CH31.08.2002
LI31.08.2002
Former [2003/46]AT15.05.2002
IE15.05.2002
NL15.05.2002
DK15.08.2002
SE15.08.2002
PT16.08.2002
CH31.08.2002
LI31.08.2002
Former [2003/39]AT15.05.2002
IE15.05.2002
NL15.05.2002
SE15.08.2002
PT16.08.2002
CH31.08.2002
LI31.08.2002
Former [2003/21]AT15.05.2002
IE15.05.2002
NL15.05.2002
SE15.08.2002
PT16.08.2002
Former [2003/17]AT15.05.2002
IE15.05.2002
NL15.05.2002
SE15.08.2002
Former [2003/10]AT15.05.2002
NL15.05.2002
SE15.08.2002
Former [2003/09]NL15.05.2002
SE15.08.2002
Former [2002/46]SE15.08.2002
Documents cited:Search[A]JPS61227518  ;
 [AP]EP0736300  (OREAL [FR]) [AP] 1-12 * examples 3-5; claims 1-25 *;
 [A]  - STN, Serveur de Bases de Données,, XP002029091 [A] 1-12 * Karlsruhe, DE, Fichier Embase, AN:94237812 * résumé *
 [A]  - STN, Serveur de Bases de Données,, XP002029092 [A] 1-12 * Karlsruhe,DE, Fichier Embase, AN:90117315 * résumé *
 [A]  - STN, Serveur de Bases de Données,, XP002029093 [A] 1-12 * Karlsruhe, DE, Fichier Medline, AN:83184944 * résumé *
 [A]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 86, no. 47, Database accession no. 86-308507, XP002029095 & JPS61227518 A 00000000 (KANEBO) [A] 1-12 * abstract *
 [A]  - STN, Serveur de Bases de Données,, XP002029094 [A] 1-12 * Karlsruhe, DE, Fichier Medline, AN:90030985 * résumé *
 [D]  - RUSHTON ET AL., "quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness", CLIN. EXP. DERMATOL., GB, (1989), vol. 14, no. 1, pages 40 - 46
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.